Naoki Fukuda

12PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyHaematological tumoursDependable systemsRadiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 15, 2025
The first case of GOLGA5-RET fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.

Takehiro Nakao, Naoki Fukuda, Xiaofei Wang

|Dec 14, 2025
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort.

Yuka Morita, Koichi Takeda, Hiroki Osumi

|May 05, 2025
Automated and Decentralized Genomic Profiling of Plasma Cell-Free DNA for Identification of Targetable and Resistance Alterations in Advanced Solid Tumors.

Hiu Ting Chan, Masumi Otaki, Naomi Hayashi

|Jan 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto

|Jun 06, 2023
Real-world clinical profile, treatment patterns and patient-reported outcomes for thyroid cancer in Japan.

Naoki Fukuda, Yoshinori Tanizawa, Kenichi Nakamura

|Jan 28, 2022
A proposed clinical scoring system for initiation of lenvatinib treatment in radioiodine-refractory thyroid cancer patients.

Naoki Fukuda, Kazuhisa Toda, Shohei Udagawa

Pageof 2

Frequent Collaborators

5 joint publications

Kenji Nakano

4 joint publications

Yasuyoshi Sato

3 joint publications

Xiaofei Wang

3 joint publications

Junichi Tomomatsu